Synergistic Effect of Vitamin D Supplementation in Patients With Vitiligo and Vitamin D Deficiency

NACompletedINTERVENTIONAL
Enrollment

29

Participants

Timeline

Start Date

May 1, 2018

Primary Completion Date

June 30, 2021

Study Completion Date

May 1, 2022

Conditions
Vitamin D DeficiencyVitiligo
Interventions
DRUG

cholecalciferol (vitamin D3)

The study group with vitamin D deficiency was treated with intramuscular injection of 200,000 IU cholecalciferol (Kwangdong Pharmaceutical Co., Seoul, Korea) once at baseline.

PROCEDURE

Phototherapy

The phototherapy for treating depigmented areas was by using 308-nm xenon chloride excimer laser (E1, Jetema, Seoul, Korea) or NB-UVB (N-UVB 6000C, Choyang medical, Seongnam, Korea). The initial dose for excimer laser was decided based on the location of depigmented lesion with consideration of the previous results of the phototherapy;40-42 eye = 100mJ/cm2; head, face, ear, neck, axilla = 150mJ/cm2; arm, leg, trunk = 200mJ/cm2; wrist = 250mJ/cm2; elbow, knee = 300mJ/cm2; hand, foot = 400mJ/cm2; finger, toe = 600mJ/cm2; Meanwhile, initial dose for NB-UVB was 400mJ/cm2. If the erythema after laser disappears within 24 hours, the energy dose was increased by 50 mJ/cm2 for each treatment. But if the erythema sustained for 24-48 hours, the energy dose was maintained. If the erythema last longer than 48 hours, the energy dose was decreased by 50-100 mJ/cm2 at each session. If blistering or pain occured, the treatment was omitted until resolution of symptoms.

Trial Locations (1)

Unknown

Kangnam Sacred Heart Hospital, Seoul

All Listed Sponsors
lead

Hallym University Kangnam Sacred Heart Hospital

OTHER

NCT05364567 - Synergistic Effect of Vitamin D Supplementation in Patients With Vitiligo and Vitamin D Deficiency | Biotech Hunter | Biotech Hunter